These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27475656)

  • 1. Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.
    Panwar B; Gutiérrez OM
    Semin Nephrol; 2016 Jul; 36(4):252-61. PubMed ID: 27475656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
    Czaya B; Faul C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.
    Ueda N; Takasawa K
    Curr Med Chem; 2017; 24(14):1417-1452. PubMed ID: 28302014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron homeostasis: transport, metabolism, and regulation.
    Guo S; Frazer DM; Anderson GJ
    Curr Opin Clin Nutr Metab Care; 2016 Jul; 19(4):276-81. PubMed ID: 27137899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Bahrainwala J; Berns JS
    Semin Nephrol; 2016 Mar; 36(2):94-8. PubMed ID: 27236129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.
    Hanudel MR; Chua K; Rappaport M; Gabayan V; Valore E; Goltzman D; Ganz T; Nemeth E; Salusky IB
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1369-F1377. PubMed ID: 27733366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease.
    Sarkar J; Potdar AA; Saidel GM
    PLoS Comput Biol; 2018 Apr; 14(4):e1006060. PubMed ID: 29659573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.
    Zumbrennen-Bullough K; Babitt JL
    Nephrol Dial Transplant; 2014 Feb; 29(2):263-73. PubMed ID: 24235084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin is a potential regulator of iron status in chronic kidney disease.
    Tsuchiya K; Nitta K
    Ther Apher Dial; 2013 Feb; 17(1):1-8. PubMed ID: 23379486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peering into the future: hepcidin testing.
    Goyal J; McCleskey B; Adamski J
    Am J Hematol; 2013 Nov; 88(11):976-8. PubMed ID: 23798368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of hepcidin in iron metabolism in inflammatory bowel diseases].
    Krawiec P; Pac-Kozuchowska E
    Postepy Hig Med Dosw (Online); 2014; 68():936-43. PubMed ID: 24988613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of iron status in chronic kidney disease.
    Gaweda AE
    Hemodial Int; 2017 Jun; 21 Suppl 1(Suppl 1):S21-S27. PubMed ID: 28328097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron Metabolism in Chronic Kidney Disease Patients.
    Honda H; Hosaka N; Ganz T; Shibata T
    Contrib Nephrol; 2019; 198():103-111. PubMed ID: 30991401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-renal-Related Mechanisms of FGF23 Pathophysiology.
    Hanudel MR; Laster M; Salusky IB
    Curr Osteoporos Rep; 2018 Dec; 16(6):724-729. PubMed ID: 30353318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker.
    van der Weerd NC; Grooteman MP; Nubé MJ; ter Wee PM; Swinkels DW; Gaillard CA
    Neth J Med; 2015 Mar; 73(3):108-18. PubMed ID: 25852110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis-independent effects of iron in chronic kidney disease.
    Patino E; Akchurin O
    Pediatr Nephrol; 2022 Apr; 37(4):777-788. PubMed ID: 34244852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.